RUNX Proteins as Epigenetic Modulators in Cancer

6Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer.

Cite

CITATION STYLE

APA

Yi, H., He, Y., Zhu, Q., & Fang, L. (2022, November 1). RUNX Proteins as Epigenetic Modulators in Cancer. Cells. MDPI. https://doi.org/10.3390/cells11223687

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free